A detailed history of Citigroup Inc transactions in Certara, Inc. stock. As of the latest transaction made, Citigroup Inc holds 82,556 shares of CERT stock, worth $987,369. This represents 0.0% of its overall portfolio holdings.

Number of Shares
82,556
Previous 77,053 7.14%
Holding current value
$987,369
Previous $1.07 Million 9.47%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$10.46 - $16.58 $57,561 - $91,239
5,503 Added 7.14%
82,556 $966,000
Q2 2024

Aug 12, 2024

BUY
$13.36 - $18.94 $45,383 - $64,339
3,397 Added 4.61%
77,053 $1.07 Million
Q1 2024

May 10, 2024

BUY
$15.65 - $19.45 $109,722 - $136,363
7,011 Added 10.52%
73,656 $1.32 Million
Q4 2023

Feb 09, 2024

SELL
$12.12 - $18.19 $136,810 - $205,328
-11,288 Reduced 14.48%
66,645 $1.17 Million
Q3 2023

Nov 09, 2023

BUY
$13.9 - $19.58 $65,510 - $92,280
4,713 Added 6.44%
77,933 $1.13 Million
Q2 2023

Aug 10, 2023

BUY
$16.89 - $24.64 $88,858 - $129,631
5,261 Added 7.74%
73,220 $1.33 Million
Q1 2023

May 11, 2023

SELL
$15.9 - $24.72 $423,623 - $658,614
-26,643 Reduced 28.16%
67,959 $1.64 Million
Q4 2022

Feb 09, 2023

SELL
$10.7 - $17.84 $226,572 - $377,762
-21,175 Reduced 18.29%
94,602 $1.52 Million
Q3 2022

Nov 10, 2022

BUY
$12.84 - $24.13 $1.1 Million - $2.07 Million
85,654 Added 284.35%
115,777 $1.54 Million
Q2 2022

Aug 10, 2022

SELL
$16.75 - $22.54 $81,807 - $110,085
-4,884 Reduced 13.95%
30,123 $646,000
Q1 2022

May 12, 2022

SELL
$17.89 - $28.73 $360,644 - $579,168
-20,159 Reduced 36.54%
35,007 $752,000
Q4 2021

Feb 10, 2022

BUY
$26.1 - $45.21 $633,029 - $1.1 Million
24,254 Added 78.46%
55,166 $1.57 Million
Q3 2021

Nov 10, 2021

BUY
$24.46 - $38.41 $756,107 - $1.19 Million
30,912 New
30,912 $1.02 Million

Others Institutions Holding CERT

About Certara, Inc.


  • Ticker CERT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 159,899,008
  • Market Cap $1.91B
  • Description
  • Certara, Inc. provides software products and technology-enabled services to customers for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access. It offers medicines to patients using biosimulation software, technology, and services to transform drug discovery and development. The company al...
More about CERT
Track This Portfolio

Track Citigroup Inc Portfolio

Follow Citigroup Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.